Modulateurs d'enzymes
Les modulateurs d'enzymes sont des composés qui peuvent augmenter ou inhiber l'activité des enzymes, régulant ainsi la vitesse des réactions biochimiques. Ces modulateurs jouent un rôle essentiel dans le contrôle des voies métaboliques, de la signalisation cellulaire et de divers processus physiologiques. Les modulateurs d'enzymes sont largement utilisés dans la recherche et le développement de médicaments pour étudier les fonctions enzymatiques et développer des agents thérapeutiques. Chez CymitQuimica, nous proposons une gamme complète de modulateurs d'enzymes de haute qualité pour soutenir vos recherches sur la régulation enzymatique et la découverte de médicaments.
Sous-catégories appartenant à la catégorie "Modulateurs d'enzymes"
693 produits trouvés pour "Modulateurs d'enzymes"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
BMS 794833
CAS :<p>ATP-competitive inhibitor of Met and VEGFR2</p>Formule :C23H15ClF2N4O3Degré de pureté :Min. 95%Masse moléculaire :468.84 g/molPanobinostat
CAS :<p>Inhibitor of histone deacetylases</p>Formule :C21H23N3O2Degré de pureté :Min. 97.5 Area-%Couleur et forme :Off-White Slightly Brown Yellow PowderMasse moléculaire :349.43 g/molDabrafenib
CAS :<p>Inhibitor of mutant B-rafV600E protein that results in decreased proliferation of cancer cells with this mutation. Treatment of metastatic melanoma in patients harboring the V600E mutation, had improved disease outcome. This antitumor activity is enhanced when combined with MEK inhibitor trametinib.</p>Formule :C23H20F3N5O2S2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :519.56 g/molGSK 126
CAS :<p>GSK-126 is a potent inhibitor of histone lysine methyl transferase 2, which is encoded by the enhancer of zeste homolog 2 gene (EZH2). The EZH2 protein regulates cell cycle as it represses the Polycomb-Repressive Complex 2 (PRC2), allowing cells to divide actively. GSK-126 inhibits the EZH2 by targeting the catalytic domain (SET) of the enzyme and therefore blocks the PCR2 repression mechanism, resulting in cell proliferation arrest. The compound has shown therapeutic potential for a variety of cancers.</p>Formule :C31H38N6O2Degré de pureté :Min. 95%Couleur et forme :White To Yellow SolidMasse moléculaire :526.30562Brigatinib
CAS :<p>Pan-ALK receptor tyrosine kinase inhibitor</p>Formule :C29H39ClN7O2PDegré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :584.09 g/molImidapril hydrochloride
CAS :<p>Angiotensin-converting enzyme inhibitor</p>Formule :C20H28ClN3O6Degré de pureté :Min. 95%Couleur et forme :White To Off-White SolidMasse moléculaire :441.16666Nilotinib - Bio-X ™
CAS :<p>Nilotinib is tyrosine kinase inhibitor drug that is used to treat chronic myeloid leukemia (CML). It inhibits the activity of the BCR-ABL protein kinase, which is involved in the development of CML. Additionally, it inhibits PDGF and c-kit for the potential treatment of various leukemias.</p>Formule :C28H22F3N7ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :529.52 g/molAbemaciclib mesylate
CAS :<p>Inhibits cyclin-dependent kinase 4 and 6 (CDK4 and CDK6); antineoplastic</p>Formule :C27H32F2N8•CH4O3SDegré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :602.7 g/molArgatroban monohydrate
CAS :<p>A reversible and selective inhibitor of thrombin that rapidly binds to the catalytic site directly. Inhibits both soluble and bound forms of thrombin. Used for prophylaxis and treatment of heparin-induced thrombocytopenia type II.</p>Formule :C23H36N6O5S•H2ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :526.65 g/molAS 1949490
CAS :<p>Inhibitor of SHIP2 phosphatase</p>Formule :C20H18ClNO2SDegré de pureté :Min. 95%Couleur et forme :SolidMasse moléculaire :371.88 g/molAminoglutethimide - Bio-X ™
CAS :Produit contrôlé<p>Aminoglutethimide is an adrenocortical steroid synthesis inhibitor that is used for the treatment of Cushing’s syndrome. This drug is an aromatase inhibitor that blocks the production of adrenal steroids. Also, this drug blocks the conversion of androgens to estrogens. Aminoglutethimide has been studied for the treatment of cancers such as breast and prostate.</p>Formule :C13H16N2O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :232.28 g/molYM155
CAS :<p>A novel survivin suppressant with an IC50 of 0.54 nM for the negative regulation of the survivin promoter.</p>Formule :C20H19BrN4O3Degré de pureté :Min. 95%Couleur et forme :Off-White PowderMasse moléculaire :443.29 g/molNeratinib maleate
CAS :<p>Irreversible ErbB receptor tyrosine kinase inhibitor</p>Formule :C30H29ClN6O3·C4H4O4Degré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :673.11 g/molSP 2509
CAS :<p>Lysine-specific demethylase 1 ( LSD1) antagonist</p>Formule :C19H20ClN3O5SDegré de pureté :(Hplc) Min. 98.0%Couleur et forme :PowderMasse moléculaire :437.9 g/molAmino tadalafil
CAS :<p>Tadalafil analogue; PDE 5 inhibitor</p>Formule :C21H18N4O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :390.39 g/molAtaciguat
CAS :<p>Activator of soluble guanylyl cyclase (sGC) which stimulates cGMP production and is effective in cells under oxidative stress. Ataciguat stimulates the heme-free form of the sGC enzyme via the sGC N-terminus of β1-subunit. Ataciguat can promote vasorelaxation and hypotension by restoring or potentiating the nitric oxide (NO) signalling pathway.</p>Formule :C21H19Cl2N3O6S3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :576.5 g/molRanolazine - Bio-X ™
CAS :<p>Ranolazine is a group P2 drug that reverses the pathogenic mechanism of myocardial infarction. It is used to treat chronic angina. It decreases myocardial wall tension and improves coronary blood flow. It inhibits the ryanodine receptor, which is responsible for regulating the release of intracellular calcium in cardiac and skeletal muscle cells. Furthermore, it is also effective at preventing atrial fibrillation and has been studied as monotherapy as well as in combination with other medications used to treat irregular heartbeat.</p>Formule :C24H33N3O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :427.54 g/molrac-Perhexiline maleate
CAS :<p>Inhibitor of CPT1 and CPT2 enzymes; inhibitor of mTORC1 kinase; anti-fungal</p>Formule :C23H39NO4Degré de pureté :Min. 97 Area-%Couleur et forme :White To Off-White SolidMasse moléculaire :393.56 g/molJNJ 38877605
CAS :<p>Potent inhibitor of c-Met catalytic activity. Selective over other tyrosine and serine-threonine kinases (600-fold selectivity). Ability to block constitutive or HGF-stimulated phosphorylation of c-Met demonstrated in vitro. JNJ 38877605 reduces radiation-induced invasion, apoptosis and proliferation of cancer cells in vitro.</p>Formule :C19H13F2N7Degré de pureté :Min. 95%Couleur et forme :SolidMasse moléculaire :377.12005Dabrafenib mesylate
CAS :<p>Inhibitor of B-Raf kinase mutant</p>Formule :C23H20F3N5O2S2·CH4O3SDegré de pureté :Min. 95%Couleur et forme :White/Off-White SolidMasse moléculaire :615.67
